3 Recruiting Neurofibromatosis Type 1 Phase 2 Clinical Trials

Active phase 2 studies for neurofibromatosis type 1 enrolling across the USA. Verify eligibility and contact site coordinators.

All Neurofibromatosis Type 1 studies

Phase 2 Studies for Neurofibromatosis Type 1

🔵 Active, Not Recruiting Phase1 / Phase2

Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN

📍 Research Site — Akron, Ohio

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Interventions for Reading Disabilities in NF1

📍 Vanderbilt University — Nashville, Tennessee

View Study & Checklist ➔

🟢 Recruiting Phase2

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

📍 University of Alabama at Birmingham — Birmingham, Alabama

View Study & Checklist ➔